Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Auzone, officially known as Shenzhen Auzone Medical Technology, is a high-tech enterprise specializing in the research, development, and commercialization of ozone-based medical technologies. The company focuses on the therapeutic applications of medical ozone for a variety of conditions, including chronic pain, non-healing wounds, and certain cardiovascular and infectious diseases. Auzone's product portfolio primarily consists of medical ozone therapy apparatuses and related clinical equipment used in hospitals and specialized clinics. By integrating advanced ozone generation technology with clinical treatment protocols, the company aims to provide minimally invasive and effective therapeutic alternatives. Auzone is recognized as a leader in the medical ozone field within the Chinese market and continues to expand its reach through clinical research and technological innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Auzone.